Minnesota Statutes
§ 62J.845 — PROHIBITION ON WITHDRAWAL OF GENERIC OR OFF-PATENT DRUGS FOR SALE
Minnesota § 62J.845
This text of Minnesota § 62J.845 (PROHIBITION ON WITHDRAWAL OF GENERIC OR OFF-PATENT DRUGS FOR SALE) is published on Counsel Stack Legal Research, covering Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Minn. Stat. § 62J.845 (2026).
Text
Subdivision 1.Prohibition.
A manufacturer of a generic or off-patent drug is prohibited from withdrawing that drug from sale or distribution within this state for the purpose of avoiding the prohibition on excessive price increases under section62J.842.
Subd. 2.Notice to board and attorney general.
Any manufacturer that intends to withdraw a generic or off-patent drug from sale or distribution within the state shall provide a written notice of withdrawal to the attorney general at least 90 days prior to the withdrawal.
Subd. 3.Financial penalty.
The attorney general shall assess a penalty of $500,000 on any manufacturer of a generic or off-patent drug that the attorney general determines has failed to comply with the requirements of this section.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
2023 c 57 art 2 s 26
Nearby Sections
15
§ 62J.01
FINDINGS§ 62J.015
PURPOSE§ 62J.016
GOALS OF RESTRUCTURING§ 62J.017
IMPLEMENTATION TIMETABLE§ 62J.03
DEFINITIONS§ 62J.0417
PAYMENT MECHANISMS IN RURAL HEALTH CARE§ 62J.052
PROVIDER COST DISCLOSURE§ 62J.06
IMMUNITY FROM LIABILITY§ 62J.156
CLOSED COMMITTEE HEARINGS§ 62J.17
EXPENDITURE REPORTING§ 62J.212
PUBLIC HEALTH GOALSCite This Page — Counsel Stack
Bluebook (online)
Minnesota § 62J.845, Counsel Stack Legal Research, https://law.counselstack.com/statute/mn/62J/62J.845.